Clinical Trial Details

Cemiplimab vs Cemiplimab plus Fianlimab in Patients with Colorectal Cancer with Minimal Residual Disease Following Definitive Surgery and Chemotherapy

IRB Protocol Number
NSABP F13

Clinical Trial Categories

  • Colorectal Cancer
Contact
Clinical Trials at 910-715-2200
How to Participate

Eligibility: Stage II/III or oligometastatic stage IV

Contact Us

For more information on participating in a clinical trial, contact us at 910-715-2200 or talk to your doctor.